The 2026 Nobel Prize in Medicine was awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for their groundbreaking work in developing optogenetics, a technique that uses light to control nerve cells. This innovation allows scientists to study the brain with unprecedented precision, offering insights into neurological diseases. The discovery emerged from Hegemann’s research on how the alga Chlamydomonas detects light, leading to the identification of light-sensitive proteins. Nagel further verified these proteins’ functions, paving the way for optogenetics. This achievement highlights the power of interdisciplinary collaboration in advancing scientific understanding.
QUESTION: How might the development of optogenetics change the way we approach treating neurological disorders in the future?
The Science Behind the Nobel-Winning Technology That Controls Neurons With Light
